Search - tctmd.com

Displaying 461 - 480 of 545

Sort: Relevancy | Date

News Daily News

Study Explores Predictors, Consequences of Stroke After TAVR

Caitlin E. Cox

November 18, 2012

News Industry News

Gore Reacts to RESPECT Trial Results

October 26, 2012

News Conference News TCT 2012

Two Trials Examine Device-Based PFO Closure

October 25, 2012

News Industry News

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

October 25, 2012

Presentation TCT 2012

Tiara (Neovasc) Program Update

Presenter: Shmuel Banai

October 24, 2012

News Conference News TCT 2012

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

October 23, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

News Industry News

FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study

October 22, 2012

News Daily News

El Apixaban tiene el Mismo Riesgo Hemorrágico que la Aspirina en Pacientes con FA

L.A. McKeown

October 10, 2012

News Daily News

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

L.A. McKeown

October 10, 2012

News Daily News

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Caitlin E. Cox

October 04, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

September 21, 2012

News Daily News

Proximal Protection During Carotid Stenting Reduces Silent Infarcts

Jason Kahn

September 14, 2012

News Daily News

PROTECT II Published: Study of Percutaneous LVAD vs. IABP Sends Mixed Signals

Caitlin E. Cox

September 10, 2012

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

News Daily News

La Morfología del Apéndice Auricular Izquierdo Podría Ayudar a Predecir el Riesgo de ACV en Pacientes con FA

July 31, 2012

Advertisement

Study Explores Predictors, Consequences of Stroke After TAVR

Gore Reacts to RESPECT Trial Results

Two Trials Examine Device-Based PFO Closure

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

Tiara (Neovasc) Program Update

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study

El Apixaban tiene el Mismo Riesgo Hemorrágico que la Aspirina en Pacientes con FA

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

Proximal Protection During Carotid Stenting Reduces Silent Infarcts

PROTECT II Published: Study of Percutaneous LVAD vs. IABP Sends Mixed Signals

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

La Morfología del Apéndice Auricular Izquierdo Podría Ayudar a Predecir el Riesgo de ACV en Pacientes con FA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content